首页> 外文期刊>Pharmaciana >IDENTIFIKASI POTENSI INTERAKSI OBAT PADA PASIEN RAWAT INAP PENYAKIT DALAM DI RSUD Prof. Dr. MARGONO SOEKARJO PURWOKERTO DENGAN METODE OBSERVASIONAL RETROSPEKTIF PERIODE NOVEMBER 2009-JANUARI 2010
【24h】

IDENTIFIKASI POTENSI INTERAKSI OBAT PADA PASIEN RAWAT INAP PENYAKIT DALAM DI RSUD Prof. Dr. MARGONO SOEKARJO PURWOKERTO DENGAN METODE OBSERVASIONAL RETROSPEKTIF PERIODE NOVEMBER 2009-JANUARI 2010

机译:RSUD中患者间药物相互作用的潜在识别博士2009年11月至2010年1月期间的玛戈诺·索卡乔·普沃克托(MARGONO SOEKARJO PURWOKERTO)

获取原文
           

摘要

The potensial drug interaction is potential action of a drug that changed or influced by other drugs concurrenly. Drug interactions are defined as a phenomenon that occurs when the pharmacokinetic effect of a drug changes due to other drug delivery. Drug interactions could cause advers drug reactions when the potential for a previously unknown interaction. The purpose of this study is to identify potential drug interactions in patient hospitalized in the Prof. Dr. Margono Soekarjo Purwokerto Hospital. The research method was an observasional retrospective study (November 2009-January 2010) by using descriptive methods for the data analysis.The result showed that the potential drug interactions in the hospitalized patients in Prof. Dr. Margono Soekarjo Hospital is 56,76% (n= 259). Based on the significance categories which proposed by Tatro (2006): a potential drug interaction with significance category 1 in ward patients in prof. Dr. Margono Soekarjo Hospital is 16,67%. The drug used thet known potential interaction, especially in the category of significance 1 should be tailored to the patient’s need, risk and benefit, and have made efforts to optimize it.
机译:潜在的药物相互作用是同时被其他药物改变或影响的药物的潜在作用。药物相互作用定义为当药物的药代动力学效应由于其他药物传递而发生变化时发生的现象。当发生以前未知的相互作用的可能性时,药物相互作用可能会引起药物反应不良。这项研究的目的是确定在Margono Soekarjo Purwokerto教授医院住院的患者中潜在的药物相互作用。该研究方法是采用描述性方法进行数据分析的观察性回顾性研究(2009年11月至2010年1月),结果表明Margono Soekarjo教授医院住院患者的潜在药物相互作用为56,76%( n = 259)。根据Tatro(2006)提出的重要性类别:教授病房患者与重要性类别1的潜在药物相互作用。 Margono Soekarjo医院的医生占16.67%。该药物使用了已知的潜在相互作用,尤其是在重要性类别1中,应针对患者的需要,风险和利益进行调整,并已努力对其进行优化。

著录项

相似文献

  • 外文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号